United States · Bill · HR
H.R. 311 (117th)
To provide for quality assurance of COVID-19 reimbursements and reporting.
Introduced
13 January 2021
Last action
—
Status
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Sponsors
—
Subjects
Discovery layer
Source updated
3 January 2025
Summary
This bill (1) establishes documentation requirements for testing, treatment, and reporting related to COVID-19 (i.e., coronavirus disease 2019); and (2) makes it unlawful to knowingly report a false diagnosis of COVID-19. To receive a federal reimbursement for the cost of a COVID-19 diagnostic test or treatment, the request for reimbursement must document that the administered COVID-19 test has been approved, cleared, or authorized by the Food and Drug Administration. Further, the Centers for Disease Control and Prevention must exclude from its official COVID-19 case and death counts any person who tested positive and requested federal reimbursement without the required documentation. Additionally, any person who knowingly reports a false diagnosis of COVID-19 is subject to criminal fines and imprisonment for not more than 10 years.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 13 January 2021
Introduced in House (PDF)
Introduced in House · EN · 13 January 2021
Introduced in House
summary · EN · 13 January 2021
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/house-bill/311
- Open data entity: https://api.congress.gov/v3/bill/117/hr/311